Watch a 39-minute webinar exploring advanced genetic discovery systems in human immune cells, presented by Dr. Theo Roth, a distinguished MD/PhD from Stanford University and UCSF. Learn about the development of non-viral genome targeting and pooled knock-in screening techniques that enable efficient genetic engineering of primary human immune cells. Discover how these innovative methods are revolutionizing cancer immunotherapy through the creation of engineered immune cell therapies. Explore the Modular Pooled Knockin Screening (ModPoKI) platform, which allows for rapid assessment of T cell genetic modifications across various cancer immunotherapy contexts. Healthcare professionals can earn PACE credits through Labroots upon completion of the webinar, valid until October 2026.
Next Generation Genetic Discovery Systems in Human Immune Cells
Overview
Syllabus
Next Generation Genetic Discovery Systems in Human Immune Cells
Taught by
Labroots
Related Courses
-
Scalable Genetic Discovery Systems for Human T Cell Therapies
-
Reprogramming Natural Killer Cells for Cancer Immunotherapy
-
The Promise and Limits of Cancer Immunotherapy - TED
-
A Living Drug That Could Change the Way We Treat Cancer - TED
-
CAR-T Cells and Cancer Immunotherapy - Part 3
-
CD3ζ as a Novel Integration Site for Reprogramming Immune Cells with Chimeric Antigen Receptors
